Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP
Professor of Pharmacy Practice
Pharmacy Clinical & Admin Sci
Phone (405) 271-2730
Fax (405) 271-6750
Office O'Donoghue Research Bldg; 1122 NE 13th St., Ste. 4415, OKC 73117
Email Peter-Johnson@ouhsc.edu
Summary
- President's Associate Presidential Professor
- Director, PGY2 Pediatric Pharmacy Residency
- Director, Pediatric Pharmacotherapy Degree Option
Publications & Presentations
- 126. Lewis T V, Johnson P N, Nebbia A M, Dunlap M. Increased enoxaparin dosing is required for obese children. Pediatrics. 2011; 127 : e787-90
127. Gish E C, Harrison D, Gormley A K, Johnson P N. Dosing evaluation of continuous intravenous fentanyl infusions in overweight children: a pilot study. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2011; 16 : 39-46
128. Johnson P N, Miller J L, Boucher E A, Lubsch L, Girotto J E, Pesaturo K A, Lee B. Pediatric Pharmacy Advocacy Group Position Statement: Medication dosing in overweight and obese children. 2010
129. Weant K A, Johnson P N, Bowers R C, Armitstead J A. Evidence-based, multidisciplinary approach to the development of a crotalidae polyvalent antivenin (CroFab) protocol at a university hospital. The Annals of pharmacotherapy. 2010; 44 : 447-55
130. Johnson P N, Harrison D, Allen C. Utility of transdermal fentanyl for prevention of iatrogenic opioid abstinence syndrome in children. Journal of opioid management. 2010; 6 : 117-24
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 1. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Avery Parman). Date: 2024.
2. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Dom Ropp). Date: 2023.
3. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Eugenie Chang). Date: 2023.
4. Society of Critical Care Medicine Presidential Citation. Date: 2022.
5. Oklahoma Foundation for Excellence. Oklahoma Medal for Excellence Finalist in Teaching and Administration. Date: 2022.
Education
- 1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.
2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.
3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.
4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.
Administrative Assignments
no results